Marketing Firsts Due As Amryt’s Filsuvez And Roche’s Lunsumio Win EU Nod
No Decision Yet On Eladocagene Exuparvovec And Olipudase Alfa
Amryt’s epidermolysis bullosa gel and Roche’s CD20xCD3 bispecific antibody for follicular lymphoma are among four drugs that have received the thumbs up from the European Medicines Agency.
